Androgen Receptor Activation Integrates Complex Transcriptional Effects in Osteoblasts, Involving the Growth Factors TGF-β and IGF-I, and Transcription Factor C/EBPδ

    July 2015 in “ Gene ”
    Thomas L. McCarthy, Michael Centrella
    Image
    Studysummary This study found that dihydrotestosterone (DHT) suppresses prostaglandin E2 and TGF-β induced IGF-I gene promoter activity in osteoblasts, suggesting complex interactions among bone growth regulators and potential complications from anabolic steroid use.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study demonstrated that dihydrotestosterone (DHT) suppressed IGF-I gene promoter activity in prostaglandin E2 (PGE2) induced osteoblasts through a C/EBP response element in exon 1 of the igf1 gene. This suppression required a functional androgen receptor (AR) and was independent of upstream Smad and Runx response elements. DHT also inhibited TGF-β induced IGF-I promoter activity but did not affect TGF-β's influence on DNA or collagen synthesis. Additionally, DHT differentially regulated other TGF-β activities, such as enhancing Smad dependent gene promoter activity. These findings highlighted the complex interactions between DHT and bone growth regulators, suggesting potential complications from anabolic steroid use in DHT sensitive tissues.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results